Can the Private Sector Save Us From Biological Catastrophe?

This panel will offer biopharma innovators and investors valuable insights into how the shifting political environment and emerging biological risks could impact their business opportunities along with broader approaches to building global health security. In an age of decreasing vaccine confidence, the expert panel will discuss a wide-range of biological risks – from rapid technology advances to climate-related disease risks – and their potential impact, including on international collaborations and the healthcare industry. Leaders should attend who are interested in exploring innovative ways that the private sector can make impactful investments in biosecurity and pandemic preparedness.

About NTI:

Founded in 2001 by Senator Sam Nunn and Ted Turner, the Nuclear Threat Initiative is a Washington, D.C.-based nonprofit, nonpartisan global security organization focused on reducing nuclear, biological, and emerging technology threats imperiling humanity.

To strengthen biosecurity and pandemic preparedness, NTI’s Global Biological Policy & Programs team (NTI | bio) works with governments, industry, academia, international organizations, and NGOs to promote global improvements and investment in biotechnology governance and national health security capacities, engage in dialogue with countries around the world to advance biosecurity, and develop innovative biothreat reduction solutions that can create lasting benefits to global security. NTI is led by CEO and Co-Chairman Ernest J. Moniz, Former U.S. Secretary of Energy, and prestigious leaders from international security, business, science, diplomacy, and policy.